MariposAI develops a continuous learning system designed to identify breast cancer risks well in advance of traditional clinical diagnosis. The platform utilizes a proprietary algorithm to analyze decades of longitudinal health data, identifying subtle physiological patterns that precede symptomatic stages. By shifting oncology from reactive treatment to proactive monitoring, the technology aims to improve patient outcomes through significantly earlier intervention. The system integrates directly with existing healthcare databases to provide scalable, data-driven insights for clinical decision support.